(NASDAQ:SAGE) hit a new 52-week high and has $164.39 target or 5.00% above today's $156.56 share price. The 9 months bullish chart indicates low risk for the $6.43 billion company. The 1-year high was reported on Dec, 7 by Barchart.com. The firm issued a buy rating and a $85.00 target price on the biopharmaceutical company's stock.
The stock increased 74.90% or $68.83 during the last trading session, reaching $160.73. About 4.65M shares traded or 445.81% up from the average. The Shareholder Yield of Sage Therapeutics, Inc. It has outperformed by 99.75% the S&P500.
Analysts await Sage Therapeutics, Inc. Three research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. Therefore 88% are positive. Sage Therapeutics now has a consensus rating of "Buy" and an average target price of $105.14.
SAGE has been the topic of several other research reports. The rating was upgraded by Chardan Capital Markets on Friday, November 10 to "Buy". Canaccord Genuity maintained Sage Therapeutics, Inc. "If the results from this trial are replicated in Phase 3 trials, SAGE-217 may meet the needs of patients with MDD for a once-daily oral treatment that potentially provides a rapid, well-tolerated and durable response with a high rate of remission".
The stock of Sage Therapeutics, Inc. As per Wednesday, March 30, the company rating was initiated by Goldman Sachs. Leerink Swann maintained the shares of SAGE in report on Thursday, September 3 with "Buy" rating. Stifel Nicolaus maintained Sage Therapeutics, Inc. The firm has "Buy" rating by Cowen & Co given on Tuesday, September 5. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. (NasdaqGM:SAGE) is -19.540182. This ratio is calculated by dividing the market value of a company by cash from operating activities. "There has been little innovation in the discovery and development of treatments for depression in the last two decades". Similarly, the Earnings Yield Five Year Average is the five year average operating income or EBIT divided by the current enterprise value. NasdaqGM:SAGE is -0.071077. Earnings Yield helps investors measure the return on investment for a given company.
Looking at some alternate time periods, the 12 month price index is 3.79279, the 24 month is 1.87946, and the 36 month is 0.46366.
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. Sage Therapeutics earned a coverage optimism score of 0.12 on Accern's scale. (NASDAQ:SAGE). Td Asset invested in 76,630 shares. Bancorporation Of Montreal Can, Ontario - Canada-based fund reported 204 shares. Sivik Ltd Liability holds 0.58% or 20,000 shares in its portfolio. Raymond James Associates reported 0% of its portfolio in Sage Therapeutics, Inc. (NASDAQ:SAGE). Dupont Capital Corp reported 13,528 shares or 0.02% of all its holdings. (NASDAQ:SAGE) for 12,232 shares.
The Earnings to Price yield of Sage Therapeutics, Inc. (NASDAQ:SAGE). Wells Fargo And Mn stated it has 0% in Sage Therapeutics, Inc. (NASDAQ:SAGE). 78,900 were reported by Gam Hldg Ag.
Buscar Company focuses on buying, breeding, racing, and selling thoroughbreds.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
Schwab Charles Investment Management Inc. increased its position in shares of Aerie Pharmaceuticals by 1.0% in the first quarter. Castleark Limited Liability Corporation has invested 0.13% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 3,711 shares.
The firm owned 56,436 shares of the real estate investment trust's stock after selling 22,689 shares during the period. American Assets Investment Management Llc decreased Ford Mtr Co Del (F) stake by 21.11% reported in 2017Q2 SEC filing.
Wealthfront Inc. boosted its holdings in Advanced Micro Devices by 0.5% in the 2nd quarter. (NASDAQ: AMD ) or 304,485 shares. In terms of Buy, Sell or Hold recommendations, Adv Micro Devices (NASDAQ: AMD ) has analysts' mean recommendation of 2.7.
Millard sent a photo to Smich on July 3rd, saying he'd rolled his first spliff. "This was Laura's body", Cameron said. She left her luggage, her money and her beloved dog behind and disappeared, the crown said.
Nomura increased their price target on Huntsman to $40.00 and gave the stock a "buy" rating in a report on Monday, October 30th. Huntsman Corporation has a beta of 0.25, offering the possibility of a higher rate of return, but also posing more risk.
Staying on top of longer-term price action may help provide investors with a wider range of reference when doing stock analysis. The F-Score may help discover companies with strengthening balance sheets. (NYSE:BNED) presently has a current ratio of 1.32.
The institutional investor owned 71,772 shares of the company's stock after buying an additional 900 shares during the period. The stock of Leggett & Platt, Incorporated (NYSE:LEG) earned "Strong Buy" rating by Raymond James on Wednesday, February 1.
Stoneridge Inv Prtn Ltd Liability holds 0.89% of its portfolio in Comcast Corporation (NASDAQ:CMCSA) for 153,986 shares. The California-based California Pub Employees Retirement System has invested 0% in Verastem, Inc. (NASDAQ:DISCA).
Year to Date (YTD) performance of American Capital Agency Corp. (NASDAQ:NURO) has "Buy" rating given on Friday, July 21 by H.C. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 1.6%.
Mother charged with aggravated manslaughter after baby's death
On November 27, MI authorities took Harris into custody without incident and she was held as a fugitive from justice without bond. A toxicology report found that Harris had alcohol, cocaine and methamphetamine in her system hours after her baby died.
Under Analyst's Radar: Nabors Industries (NBR)
It represents a security's price that, if achieved, results in a trader recognizing the best possible outcome for his investment. The fund owned 570,216 shares of the oil and gas company's stock after buying an additional 23,443 shares during the period.
Traveling Deals for the Clemson Playoff Game
Could you imagine the controversy if only four teams made the NCAA men's basketball tournament? Clemson retains its number 1 spot. But miss the Clemson-Alabama game? The teams played another thriller last season and Clemson took the title in Tampa, Florida.
Actor Vishal mourns the death of democracy
Sumathi and Deepan had backtracked under pressure from the ruling party and he was anxious about their safety. Vishal had announced on December 2 that he would be contesting in the upcoming bypoll from RK Nagar.
UP mayors deployed in Gujarat
The BJP is all set to encash its Uttar Pradesh civic poll performance in Gujarat by utilising newly elected mayors for campaigning here.
Analysts See $1.04 EPS for Apogee Enterprises, Inc. (APOG)
Koch Industries Inc. purchased a new stake in shares of Apogee Enterprises in the second quarter valued at about $309,000. The stock of Lowe's Companies, Inc. (NYSE:LOW) earned "Outperform" rating by Credit Suisse on Thursday, August 24.
Major banks slip ahead of RBI monetary policy outcome
That's also contributing to a surge in prices, together with rising global oil costs and higher wages for government employees. The S&P BSE Sensex dropped 0.63 percent at 32,597 while the broader NSE Nifty declined 0.73 percent to 10,044.
Bitcoin price punches through $12000 reaching new high
Remember, Bitcoin was valued at around $1,000 at the beginning of the year, but really began its big run over the last two months. According to CoinMarketCap , bitcoin has risen 9.63 percent in 24 hours, and 18.74 percent over the last 7 days.